Several genome-wide association studies have linked mutations in the IL-10 signaling pathway with inflammatory bowel diseases in humans (47-51), and previous studies in mice have shown that blocking IL-10 signaling can alter the differentiation of H. hepaticus-specific T cells from TREG cells to TH17 cells (5, 11). Here, IL10 is linked to inflammatory bowel disease.